PO56 WHETHER CHIDAMIDE IMPROVES THE RESPONSE TO CISPLATIN IN FIRST-LINE TREATMENT OF METASTATIC TRIPLE-NEGATIVE BREAST CANCER

Category Primary study
JournalBreast
Year 2021
This article has no abstract
Epistemonikos ID: 0fe349601c2d94e5a7c8b152d1749f7067530172
First added on: Feb 13, 2025